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S-nitrosylationS-nitrosylation is associated with signal transduction and microbicidal activity of nitric oxide (NO). We have
recently described the S-nitrosylation ofMycobacterium tuberculosis protein tyrosine phosphatase A, PtpA, an
enzyme that plays an important role in mycobacteria survival inside macrophages. This post-translational
modiﬁcation decreases the activity of the enzyme upon modiﬁcation of a single Cys residue, C53. The aim
of the present work was the investigation of the effect of S-nitrosylation in PtpA kinetic parameters, thermal
stability and structure. It was observed that the KM of nitrosylated PtpA was similar to its unmodiﬁed form,
but the Vmax was signiﬁcantly reduced. In contrast, treatment of PtpA C53A with GSNO, did not alter either
KM or Vmax. These results conﬁrmed that PtpA S-nitrosylation occurs speciﬁcally in the non-catalytic C53
and that this modiﬁcation does not affect substrate afﬁnity. Using circular dichroism (CD) and nuclear mag-
netic resonance (NMR) spectroscopy techniques it was shown that PtpA S-nitrosylation decreased protein
thermal stability and promoted a local effect in the surroundings of the C53 residue, which interfered in
both protein stability and function.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
The protein tyrosine phosphatase superfamily comprises several
groups of proteins that are involved in post-translational modiﬁca-
tion activity [1–3]. The deregulation of these proteins in eukaryotes
is associated with various diseases, including Alzheimer, diabetes,
obesity and cancer [4–6].
In Mycobacterium tuberculosis two secreted tyrosine phosphatases,
PtpA and PtpB, were identiﬁed and associated to the infection process
and disease [7]. PtpA inactivation attenuates M. tuberculosis growth in
human macrophages. Furthermore, it was shown that PtpA interferes
with host signaling pathways within infected macrophages [8]. For ex-
ample, PtpA participates in the inhibition of mycobacterial phagosome
acidiﬁcation due to the interaction with subunit H of the macrophage
vacuolar-H+-ATPase (V-ATPase) located in the phagosome membrane
[9].
PtpA is classiﬁed as a low molecular weight (LMW) tyrosine
phosphatase based on crystallographic data, and presents a classic
Rossmann fold, with two right-handed βαβ motifs contributing to
the central four-stranded parallel β-sheet. PtpA exhibits the common
catalytic mechanism of dephosphorylation involving the conserved
active-site sequence motif C(X)5R(S/T), which is called the protein.
 OA license.tyrosine phosphate-binding loop (PTP loop). By comparison with
mammalian low molecular weight phosphatases, it was speculated
that PtpA phosphate-binding loop seems to be less stable than in
mammalian PTPs. There are considerable evidences that the variable
loop plays a key role in determining the nature of the substrate, so
that it might help the enzyme to recognize different types of sub-
strates [10].
Regarding post-translational modiﬁcation, tyrosine phosphatases
can be reversibly S-nitrosylated by nitric oxide (NO), the covalent
addition of a NOmoiety to the sulfur atom of a cysteine residue. Reac-
tive nitrogen species (RNS) may function as typical second messen-
gers to transiently control the activity of signaling modulators [1].
NO has been also shown to modulate cGMP-independent pathways
by modifying a multitude of cellular biomolecules containing reactive
metal centers, as well as cysteine residues [11].
The post-translational modiﬁcation by NO has been recently in-
vestigated in several proteins at the structural level. High-resolution
crystal structures have been solved for a number of heme proteins
[12], PTP1B [1] and thioredoxin [13]. Although NO is able to modulate
the activity of tyrosine phosphatases, the molecular basis of NO
modiﬁcation and the subsequent effect on enzyme activity are not
completely understood.
NO is believed to exert its effects on proteins by direct modiﬁca-
tion of a residue important for protein structure or enzymatic cataly-
sis [1]. We have recently reported, using a molecular biology
approach, that PtpA non-catalytic cysteine (C53) is modiﬁed by NO.
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PtpA activity has not yet been assessed [14]. No complete NMR struc-
ture for PtpA has been published, although sequential backbone reso-
nance assignments are available (BMRB ID: 6722) [16]. In this paper
we show that the S-nitrosylation of a non-catalytic cysteine is able
to modify the stability and the function of PtpA, and we suggest a
mechanism to explain its catalytic activity inhibition.
2. Material and methods
2.1. Site-directed mutagenesis
The site-directed mutagenesis of PtpA was carried out as described
in [14]. The following double and triple mutants were obtained: C11A/
C16A, C11A/C53A, C16A/C53A and C11A/C16A/C53A. These mutations
were veriﬁed by DNA sequencing.
2.2. Biotin switch assay and mass spectrometry
The biotin switch technique was carried out on puriﬁed proteins as
described in [14]. In-gel digestion of the protein spots was carried out
according to [17] with some modiﬁcations. Gel spots of biotinylated
and non-biotinylated proteins were repeatedly destained in 25 mM
ammonium bicarbonate in 50% acetonitrile until gel slices became col-
orless. The gel pieces were dehydrated with 100 μl of 100% acetonitrile.
The gel pieces were then dried under a vacuum system (Eppendorf,
Hamburg, Germany). After drying, gel fragments were rehydrated
on ice in 10 μl of sequencing grade modiﬁed trypsin (10 μg/ml in
25 mMammonium bicarbonate) (Promega, Madison,WI) and incubat-
ed for 16 h at 37 °C. The tryptic peptides were extracted with
two washing steps containing 45 μl of 50% acetonitrile in 5%
triﬂuoroacetic acid (TFA) for 30 min. Then, the concentrated peptide
extracts were dried under a vacuum system. Extracted peptides were
resuspended in 10 μl 0.1% TFA and a sample of 1 μl of concentrated di-
gest was mixed with 1 μl of a saturated matrix solution of α-cyano
4-hydroxycinnamic acid (5 mg/ml in 0.1% TFA and 50% acetonitrile).
This mixture was spotted on the MALDI target plate (Bruker Daltonics,
Bremen, Germany) and allowed to crystallize at room temperature.
MS andMS/MS analyseswere performed on aMALDI-TOF/TOFAutoﬂex
III Smartbeanmass spectrometer (Bruker Daltonics, Bremen, Germany).
The MS spectra were acquired in positive ion mode, using an accelerat-
ing voltage of 20 kV and laser frequency of 200 Hz. LIFT mass spectra
were acquired in the positive ion mode. Metastable fragmentation
was induced by a nitrogen laser (337 nm), accelerated to 6 kV and se-
lected in a timed ion gate. In the LIFT-cell the fragmentswere further ac-
celerated to 19 kV. External calibration was performed using peptide
standards. The spectra generated were analyzed by the FlexAnalysis
3.3 software (Bruker Daltonics, Bremen, Germany).
2.3. Enzyme assays
The phosphatase activity of wild-type PtpA and mutants was
assayed as described in [14]. In order to determine the kinetic parame-
ter values (KM, Vmax and kcat) of PtpAwild-type andmutant C53A in the
presence or absence of NO, a range of pNPP concentrations (0.2, 0.4, 0.8,
1.6, 3.2, 6.4 and 12.8 mM) was used. The standard reaction was carried
out in a ﬁnal volume of 200 μl containing 20 mM imidazole pH 7.0,
50 nM of enzyme and 20 mM p-nitrophenyl phosphate (pNPP) at
37 °C. The assays were started by the addition of the substrate and the
release of p-nitrophenol (pNP) was determined from the A410 detected
for 10 min using a microplate spectrophotometer (Tecan Inﬁnite
M200). The molar absorptivity of pNP under these assay conditions
was 3061.99 M−1cm−1. The spontaneous hydrolysis of pNPP was
subtracted from each reaction. The effect of nitrosylation on protein ac-
tivity was assayed using S-nitrosoglutathione (GSNO) as a NO donor,
and glutathione as a negative control. In this case, the enzymes werepre-incubated with 1 mM GSNO or GSH for 30 min at 25 °C in the
dark. The enzymatic hydrolysis of pNPP in the presence of GSNO or
GSH was determined as described above. The speciﬁc activity was de-
ﬁned as the release of 1 μmolpNP min−1mg−1 of protein at 37 °C.
The kinetic constants were evaluated by ﬁtting the data to the
Michaelis–Menten equations using non-linear regression analysis in
GraphPad Prism 5.0 software package. All reactions were performed
in quadruplicate.
2.4. Circular dichroism spectroscopy
The PtpA wild type and mutant forms at 10 μM were dialyzed
against buffer (10 mM Hepes, pH 7.4). Spectroscopic analyses were
carried out in a JASCO J-815 spectropolarimeter equipped with a
Peltier temperature control unit. Circular dichroism was measured
in a 0.05 cm pathlength cuvette (50 nm/min scan speed, response
time 8 s, bandwidth 2 nm, and data pitch 0.1 nm s−1) with an aver-
age of 3 scans for each spectrum in a wavelength range from 190 nm
to 260 nm. Thermal unfolding was carried out at 20 μM protein con-
centration by increasing the temperature of the cuvette from 20 °C to
60 °C, and monitoring the 222 nm peak. The effect of nitrosylation on
protein thermal stability was assayed using GSNO as a NO donor, and
glutathione as a negative control. The enzymes were pre-incubated
with 1 mM GSNO or GSH for 30 min at 25 °C in the dark. In order to
verify the reversibility of PtpA C53 S-nitrosylation, the samples
were incubated with 1 mM DTT after GSNO treatment.
2.5. Nuclear magnetic resonance analysis
The double labeled recombinant PtpA was expressed in
Escherichia coli BL21(DE3) as a fusion tagged protein as described
[14]. For structure analysis experiments isotopically labeled mole-
cules (15N and 15N/13C at 100 μM) were prepared in 50 mM Hepes,
pH 7.5, 1 mM EDTA containing 10% D2O. NMR experiments for assign-
ment veriﬁcation were acquired at 298 K using a Bruker Avance
DRX 600 MHz equipped with a three-axis gradient 5 mm cryoprobe.
The 3D triple-resonance spectrum HNCA was collected to conﬁrm
the previous reported sequential backbone resonance assignments
(BMRB ID: 6722).
PtpA–GSNO chemical shift perturbation was monitored by 1H/15N
HSQCs experiments (1024×256 points) using 100 μM PtpA and differ-
ent concentrations of GSNO, titrated from 0 to 1 mM. Evaluation of
GSNO effect was based on chemical shift deviations compared to a con-
trol sample without GSNO. To avoid any interference from themedium,
all experiments were conducted in the same buffer conditions. The
chemical shift perturbations (CSPs) from the 2D 15N–1H HSQCNMR ex-
periments were used to identify the GSNO effect upon PtpA structure
using the following equation: CSP=[(ΔNH)2+(Δ15N/10)2]1/2. The
ΔNH is the difference between free and bound 1H amide chemical shifts
(ppm) and the Δ15N is the difference between free and bound 15N
chemical shifts (ppm).
3. Results
In our previous work [14], PtpA mutants C11A, C16A and C53A
were screened to evaluate their S-nitrosylation potential upon treat-
ment with different NO donors. In order to clarify the involvement
of C53 in S-nitrosylation and its effects on structure–function
relationship, in the present work double and triple mutants were pro-
duced. These double and triple mutants were obtained by site-
directed mutagenesis and were subjected to the biotin switch assay.
Using the biotin switch assay, it was conﬁrmed that the absence of
C53 residue in mutants C53A, C53A/C11A, C53A/C16A and C53A/
C11A/C16A resulted in proteins unable to be S-nitrosylated and,
hence, biotinylated (Fig. S1). Peptide sequencing using MALDI/
TOF-TOF conﬁrmed the biotinylation of C53 residue in PtpA after
Table 1
Catalytic activity parameters of PtpA (Vmax, KM and kcat) after GSNO treatment.
Vmax





PtpA WT 41.15±1.23 1.44±0.14 13.73±0.41
PtpA WT+GSNO 20.12±0.62 1.33±0.13 6.71±0.21
PtpA C53A 41.88±2.36 1.44±0.26 13.97±0.79
PtpA C53A+GSNO 36.70±1.40 1.38±0.17 12.24±0.47
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biotinylated (Fig. S2). We also checked if other GSNO potential mod-
iﬁcations of Cys residues beyond S-nitrosylation, for example,
sulfenylation, were occurring upon treatment. Mass spectrometry in-
dicated that only nitrosylation is observed, without other detectable
modiﬁcations (not shown).
The speciﬁc enzymatic activities of double and triple cysteine mu-
tants were measured to evaluate the contribution of each cysteine to
the nitrosylation effect on PtpA, and to further support and comple-
ment our original data [14]. In our previous work, it was shown
both that the single mutant C53A presents a catalytic activity similar
to that of wild type, and that the single mutant C16A presents a lower
activity when compared to PtpA wild type. In addition, the single mu-
tant C11A is inactive [14]. We also showed that wild type PtpA and
the single mutant C16A activities are reduced upon GSNO treatment
while the single mutant C53A activity remained similar to the
untreated form. We now assessed the activity of the double and triple
cysteine mutants and we observed that the double mutant C16A/
C53A activity is similar to the single mutant C16A activity and, in
the same way as C53A, it is not inhibited by S-nitrosylation (Fig. S3).
Initial reaction rates at various pNPP concentrations were measured
(Fig. 1). Data curve ﬁtting resulted in a KM of 1.44±0.14 mM for the
wild type and 1.44±0.26 mM for the C53A mutant. For wild type PtpA
the parameters Vmax and kcat were 41.15±1.23 μmol pNP min−1mg−1
and 13.73±0.41 s−1 respectively, while C53A mutant shows a Vmax
value of 41.88±2.36 μmol pNP min−1mg−1 and a kcat value of
13.73±0.41 s−1. Thereby, the C53Amutation does not affect the kinetic
parameters of the enzyme. On the other hand, when PtpA wild type
is S-nitrosylated, Vmax and kcat were reduced by half (20.12±
0.62 μmol pNP min−1mg−1 and 6.71±0.21 s−1 respectively), while
the KM value remained unchanged (1.33±0.13 mM). In contrast, the
C53Amutant did not suffer signiﬁcant changes in the kinetic parameters
upon addition of NO donor — KM (1.38±0.17 mM), Vmax (36.70±
1.40 μmol pNP min−1mg−1) and kcat (12.24±0.47 s−1) (Fig. 1 and
Table 1). These results indicate a direct effect of S-nitrosylation on the
catalytic activity of PtpA rather than on substrate binding afﬁnity.Fig. 1. Kinetics of PtpA wild type and C53A, respectively, is shown. All experiments
were performed in quadruplicate, (***) pb0.001.In order to evaluate the structural stability of PtpA upon
S-nitrosylation, circular dichroism (CD) analysis was carried out
with wild type PtpA and the cysteine mutants. The CD data obtained
for wild-type PtpA suggests a typical α-helical secondary structure
proﬁle with minimal peaks at 208 nm and 222 nm. The deconvoluted
spectrum obtained by CDSSTR analysis of wild type PtpA suggests a
mixed content of α-helical (56%) and β-sheet (11%) secondary struc-
tures [15]. The CONTIN method also indicated similar values, with
53% of α-helices and 5% of β-sheets [15]. It was observed that C11A,
C16A, C53A, C11A/C53A and C16A/C53A mutants have the same con-
tent of secondary structure than wild type PtpA, while C11A/C16A
and C11A/C16A/C53A mutants present an apparently different fold
(Fig. S4). In these double and triple mutants a reduction of about
30% in the α-helical secondary structure content was observed
(according to CDSSTR and CONTIN methods). This reduction highlights
the importance of C11/C16 residue pair to the PtpA fold. When the NO
donor (GSNO) was added to wild type PtpA, the overall far-UV spec-
trum was very similar (Fig. S5), indicating that S-nitrosylation of PtpA
does not affect the secondary structure proﬁle.
The thermal denaturation proﬁle of PtpA, detected by changes in
CD upon thermal treatment, shows a melting temperature (TM) of
40.4 °C. The C53A mutant shows a similar TM, 40.8 °C, while C11A,
C16A, C11A/C53A and C16A/C53Amutants have lower thermal stabil-
ity (37.6, 33.3, 38.7 and 34.6 °C respectively). On the other hand,
when PtpA wild type was S-nitrosylated, the thermal denaturation
proﬁle indicated a decrease of 4.2±0.6 °C in the melting temperature
when compared to the non-nitrosylated enzyme. It is important to
note that after DTT treatment, the original denaturation proﬁle of
the wild type PtpA treated with GSNO is restored, demonstrating
the reversibility of C53 S-nitrosylation (Fig. 2A). To conﬁrm that this
lower PtpA thermal stability resulted from C53 modiﬁcation by NO,
the PtpA mutants were also evaluated in this regard. The denatur-
ation proﬁle of C53A mutant in the presence of GSNO was similar to
the untreated form suggesting that, indeed, C53 is the nitrosylation
target (Fig. 2B). The C11A (Fig. 2C) and C16A (Fig. 2E) mutants have
also a lower TM value after GSNO treatment, in comparison to the
non-nitrosylated forms (36.1 and 30.1 °C respectively), while C11A/
C53A (Fig. 2D) and C16A/C53A (Fig. 2F) mutants do not show signif-
icant differences between treated and untreated samples with GSNO
(38.9 and 34.1 °C respectively). Altogether, the differences observed
in TM values suggest that the addition of NO to PtpA affects protein
stability through C53 modiﬁcation (Table 2 and Fig. 3).
In order to further analyse C53 nitrosylation and to evaluate which
surrounding residues are affected by this modiﬁcation, triple resonance
NMR experiments using 13C/15N samples were carried out. Chemical
shift assignments deposited in the BMRB (ID: 6722) [16] were used as
a reference to re-assign the PtpA backbone through triple resonance ex-
periments. The majority of chemical shift assignments reported were
identiﬁed in PtpA, except for the residues Leu 99 and Val 140. The as-
signment of all residues was also conﬁrmed through HNCA experiment.
The doubly labeled PtpAwas titratedwith GSNO (100 μMto1 mM) and
the chemical shift deviation was evaluated by comparison with the
untreated control. At 1 mM GSNO concentration, residues G51, S52,
R57, R72 and A73 presented chemical shift deviation higher than the
mean plus two standard deviations. Minor disturbances higher than
Fig. 2. Thermal denaturation proﬁle of PtpA wild type (A) and C53A mutant (B), upon GSNO treatment. When GSNO was added to PtpA, the TM decreased 4.2±0.6 °C, while sig-
niﬁcant difference in C53A mutant was not observed (0.9±0.4 °C). After DTT treatment the wild type PtpA–NO of the original denaturation proﬁle is restored. The C16A (C) and
C11A (E) mutants also show a lower TM value after GSNO comparing to an untreated form while C16A/C53A (D) and C11A/C53A (F) mutants do not show this change.
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dues A54, A58, L62, S117, D123, S133 and A145. Even with lower
GSNO concentration (100 μM), it was also observed that residues S52,
D55, R57 and A58 were affected by NO. The majority of residues were
located in the variable loop around C53 (Fig. S6). To verify if the modi-
ﬁed residues were indeed affected by NO, the GSNO-treated PtpA was
chemically reduced with DTT in order to disrupt the Cys–NO link.
After 1 mM GSNO treatment of PtpA followed by DTT addition, theTable 2
Average values of TM (°C) of PtpAwt andmutants after GSH (1 mM), GSNO (1 mM) and
GSNO (1 mM)+DTT (1 mM) treatment.
GSH GSNO GSNO+DTT
PtpA WT 40.4±1.2 35.6±0.4 39.9±1.0
PtpA C53A 40.8±0.6 39.7±0.5 40.4±0.3
PtpA C11A 37.6±0.1 36.1±0.1 37.9±0.5
PtpA C11A/C53A 38.7±0.4 38.9±0.2 39.2±0.1
PtpA C16A 33.3±0.3 30.1±0.1 32.6±0.3
PtpA C16A/C53A 34.6±0.3 34.1±0.2 34.3±0.2reversibility of chemical shift values upon DTT treatmentwas observed,
conﬁrming that NO is modifying the surrounding residues of C53
(Fig. 4).Fig. 3. TM deviation of PtpA wild type and mutants after GSNO treatment. The differ-
ences observed in TM values suggest that the S-nitrosylated C53 affects protein thermal
stability. All experiments were performed in triplicate. (***) pb0.001, (**) pb0.01.
Fig. 4. Effect of GSNO treatment on wild type PtpA chemical shifts monitored by 15N HSQC. In panel A, chemical shift perturbation (CSP) after 1 mM GSNO addition. The higher
deviations are colored in blue, surrounding the Cys53. Minor effects are shown in cyan. In panel B, amino acid three-dimensional locations depicted on PtpA structure (PDB:
1U2P). Cysteine residues are highlighted in red color.
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The catalytic site of PTPs usually contains a cysteine residue whose
SH-group exists in the thiolate state (S−) to enable catalysis. The cat-
alytic cysteines usually present pKa values ranging from 4 to 6 and
this fact has been associated to higher susceptibility to oxidation
and nitrosylation [18]. The results presented in this paper corroborate
the results obtained in our previous work, and conﬁrm that the cata-
lytic cysteine residue of PtpA (C11) from M. tuberculosis, which func-
tions as a phosphate acceptor in the ﬁrst step of catalysis, is not
directly involved in the nitrosylation signaling. The non-catalytic
C53 is the best candidate to play this role in PtpA. Nevertheless, the
protein enzymatic activity is clearly affected by GSNO. In order to fur-
ther investigate the role of S-nitrosylation on PtpA activity, in the
present work our focus was directed toward the study of its kinetic
parameters and structural stability.
It was observed that the KM of nitrosylated PtpA (1.4±0.1 mM)
was similar to its unmodiﬁed form (1.3±0.1 mM), but the Vmax
was reduced from 41.2±1.2 to 20.1±0.6 μmol pNP min−1mg−1
after GSNO treatment. In contrast, C53A treated with GSNO showed
a Vmax similar to the untreated form, 36.7±1.4 and 41.8±
2.4 μmol pNP min−1mg−1, respectively (Table 1). These results con-
ﬁrm that S-nitrosylation occurs speciﬁcally in the non-catalytic C53
and this modiﬁcation does not affect substrate afﬁnity.
According to the reported 3DPtpA structure (PDB ID: 1U2P) [10], the
protein exhibits a classic Rossmann fold, an α/β motif with two
right-handed βαβmotifs contributing to the central four-stranded par-
allel β-sheet. The deconvoluted spectrum obtained by CDSSTR analysis
[15] with the WT PtpA suggests a mix content of α-helical (56%) and
β-sheet (11%) secondary structures, in agreementwith proteins belong-
ing to the tyrosine phosphatase fold [10] and with the M. tuberculosis
PtpA structure that shows about 40% α-helices and 12% β-sheets [10].
The structural information obtained by CD spectroscopy indicates that
C53, when nitrosylated by GSNO, affects the PtpA protein stability
(Fig. 2). When the PtpA structure is inspected we observe that C11
and C16 are located in the catalytic loop and C53 is in the surface of
the so-called variable loop. The low pKa value of the catalytic cysteine
is usually attributed to the increased reactivity with NO [18,19], but
the existence of a typical chemical environment condition or a structur-
al motif that promotes this interaction is unknown. Recently, Marino
and Gladyshev [19] showed that the proximal acid–base motif, lowcysteine pKa, hydrophobicity or sulfur atom exposure do not deﬁne
the speciﬁcity of S-nitrosylation. In PtpA, the cysteine residue affected,
outside of the catalytic loop, is in the vicinity of residues associated to li-
gand binding and accessibility. The amino acid residueD123,whichmay
form electrostatic or hydrogen bond interactionwith R17 (a key residue
for catalysis) [10], presents chemical shift deviations upon GSNO
treatment in PtpA, suggesting a direct inﬂuence in the catalytic site. In
Bacillus subtilis PTP, the loop with the homologous residue D115 is in-
volved in substrate binding [20]. It is important to note that the afﬁnity
constant of nitrosylated PtpA has shown similar values to the unbound
pNPP substrate form, which suggests, at least for this substrate, that the
ligand accessibility is not critical to nitrosylated PtpA. As demonstrated
by Williams and co-workers [11] using NMR technique, the NO modiﬁ-
cation of p21ras, a guanine nucleotide-binding protein, does not support
a relevant conformational change, but, as also shown in PtpA, affects the
protein activity. When the amino acid sequences from several LMW
PTPs are analyzed, it becomes clear that the C53 position is unusual
[10]. The reduced stability and activity of S-nitrosylated PtpA occurs
through a non-conserved residue modiﬁcation in the variable loop,
which indicates that this phenomenonmay not be extended as a gener-
al rule in PTPs.
According to our data, a reasonable factor that explains the re-
duced activity upon PtpA nitrosylation is the protein instability,
which results in less active sites available for substrate binding.Acknowledgements
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